VX/273 (Oratuss 12 60 mg-600 mg-15 mg)
Generic Name: carbetapentane/guaifenesin/phenylephrine
Pill with imprint VX/273 is White, and has been identified as Oratuss 12 60 mg-600 mg-15 mg. It is supplied by Vindex Pharmaceuticals.
Oratuss 12 is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. FDA has not classified the drug for risk during pregnancy. Oratuss 12 60 mg-600 mg-15 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for VX/273
- Generic Name:
- 60 mg-600 mg-15 mg
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Vindex Pharmaceuticals
- National Drug Code (NDC):
More about Oratuss 12 (carbetapentane / guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.